Summary
Mild cognitive impairment (MCI), defined as the “pre-dementia stage on the continuum of cognitive decline, characterized by objective impairment in cognition that is not severe enough to require help with usual activities of daily living”, tends to occur in between 10% to 20% of people aged 65 years and older. Risk of MCI increases with age, and men are at a slightly higher risk than women.
This clinical review examines the evidence concerning the diagnosis, treatment, and prognosis of MCI. There are no medications of proven efficacy for MCI currently. Aerobic exercise, mental activity, and social engagement may help prevent further cognitive decline.
Full Text Link (Note: This article requires a suitable Athens password, a journal subscription or payment for access).
Reference
Langa, KM. Levine, DA. (2014). The diagnosis and management of mild cognitive impairment: a clinical review. JAMA, December 17th 2014, Vol.312(23), pp.2551-61. (Click here to view the PubMed abstract).
